DAXISPHARMA
ActiveSummary
DAXISPHARMA has been active since 1980 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6.0m and a net result of €166,396. Equity remains stable across the filed fiscal years (±1.9% per year). Its solvency ranks better than 26% of 6033 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
History
Acts, filings and financial milestones
03-08
State Gazette act
RestructuringMerger · Shareholding · Board composition36 facts ▸
- Merger, fusion simplifiée, intégralité du patrimoine, tant activement que passivement
- Shareholding, Servier Benelux, SA
- Shareholding, Servier Benelux, SA
- Shareholding, Servier Benelux, SA
- Board composition, Ziad MATTA (managing director)
- Board composition, SERVIER NEDERLAND B.V. (director)
- Board composition, ARTS ET TECHNIQUES DU PROGRES, SAS (director)
- Board composition, Ziad MATTA (managing director)
- Board composition, François VILETTE (director)
- Board composition, Stéphane MASCARAU (director)
- Board composition, Ziad MATTA (managing director)
- Board composition, François VILETTE (director)
- +24 further facts in this act
10-06
State Gazette act
Reappointments: Ziad Matta, Stéphane Mascarau and François VilettePower of attorney7 facts ▸
- General meeting, 04-03-2026
- Power of attorney, Coralie-Anne Tilleux
- Power of attorney, Luus Hillen
- Power of attorney, ebl redsky
- Director reappointment, Ziad Matta (managing director)
- Director reappointment, Stéphane Mascarau (director)
- Director reappointment, François Vilette (director)
24-03
State Gazette act
Registered officeRegistered-office move2 facts ▸
- Board meeting, 03-02-2026
- Registered-office move, Chaussée de Mons 1424,1070 Bruxelles (Anderlecht)
Show earlier events
About the unread acts
Of the 28 Belgian State Gazette acts we know for this company, 3 have been read. The other 25 have not been read yet: what they contain is neither established nor disproved here.